WallSt Focus
Total 496 Posts
SmallCaps Daily Sits Down with Milton Werner, President and CEO of Inhibikase Therapeutics
CEO and President, Milton Werner shares Inhibikase's vision, achievements, and future endeavors in neurological diseases while highlighting the significant progress of the company's lead candidate, risvodetinib, in its Phase 2 trial for Parkinson's.
January Jobs Report Surges Past Estimates, Raising Questions for Fed Policy
The US labor market surpassed previous expectations this January, coming out of the gates with a much stronger-than-anticipated 353,000 nonfarm payroll jobs added, surpassing economists' expectations of 185,000.
Stock Market Today: Tech Extends Rally, S&P 500 Eyes Record Close
Tech giants came out on top this Wednesday, sending the S&P 500 towards another all-time high as Netflix's subscriber surge sent growth stocks soaring.
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."
Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is thrilled to announce a milestone in its innovative Laetose™ technology platform. The U.S. Patent and Trademark Office (USPTO) has issued U.S. patent # 11,898,184, entitled "Low Glycemic Sugar C...
Amesite Launches Implicit Bias Training with Expert Larry Davis Jr.
Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, announces the launch of its Implicit Bias Training program.
Windtree Eliminates $15 Million Contingent Liability to Deerfield Management Company
Windtree Therapeutics, Inc. (NasdaqCM: WINT), today announced that the Company entered an Exchange and Termination Agreement with affiliates of Deerfield Management Company to receive up to $15,000,000 in development and commercial milestone payments associated with AEROSURF®.
Is Bank First Corporation the Next Big Investment Jackpot? Unveiling the Surprising Financial Turnaround of 2023!
Bank First Corporation reported a staggering net income of $34.9 million for the fourth quarter, and an even more impressive $74.5 million for the year ended December 31, 2023.